Skip to content

Study to see the effect of radiotherapy in preventing recurrence of keloids after surgical excision

Outcome analysis of adjuvant radiotherapy after surgical excision in keloids - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/02/080106
Enrollment
42
Registered
2025-02-07
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L00-L99- Diseases of the skin and subcutaneous tissue

Interventions

Intervention1: Low dose radiation post keloid excision: 12Gy radiation in 3 fractions over 3 days starting within 24 hours of the surgical excision Intervention2: NIL: NIL

Sponsors

All India Institute of Medical Sciences, Raipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients presenting with keloid in any part of the body that are planned for excision followed by primary closure or flap closure where no residual open wound is left after excision

Exclusion criteria

Exclusion criteria: i. Uncontrolled diabetes ii. Uncontrolled hypertension iii. Pregnancy iv. Connective tissue disorder v. Prior radiotherapy to same part vi. Patients in whom after keloid excision the wound is not primarily closed or grafted are excluded as adjuvant radiation cannot be applied over open wound

Design outcomes

Primary

MeasureTime frame
To analyze recurrence of keloid after postoperative radiotherapyTimepoint: Immediate post operative asessment, suture removal at day 14, follow up at 3 months, 6 months, 9 months and 12 months from surgery

Secondary

MeasureTime frame
Incidence of complication in post operative patients including wound dehiscence , infection , erythema Patient and observer evaluation using the Patient and Observer Scar Assessment Scale (POSAS)Timepoint: 3 monthly follow up for 1 year

Countries

India

Contacts

Public ContactJiten Kumar Mishra

All India Institute of Medical Sciences, Raipur

mishra.jitenkumar@gmail.com9437616743

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026